Form D · Biotechnology

Aragen Bioscience, Inc.

Morgan Hill, CA · CIK 0001594773

Offering snapshot reported Jan 28, 2015 · SEC filing

Reported sold
$2.72M
Offering amount: $3.73M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 10, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.36M$2.72MJan 28, 2014: $2,719,193.00Jan 28, 2014Jan 28, 2015: $2,719,193.00Jan 28, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 28, 2015Amendment$2,719,193$0vs Jan 28, 20141SEC filing
Jan 28, 2014Initial$2,719,193No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-210871
Common Stock to be issued in three tranches and Series B Preferred Stock to be issued in tranche 1.

Source: Form D, filed Jan 28, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
J.B. Gupta Director
Manmahesh Kantipudi Director
Christian C. Simonsen Executive
William R. Srigley Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
380 Woodview Avenue
Morgan Hill, CA, 95037